CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Update

by · The Cerbat Gem

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the recipient of a significant decline in short interest in November. As of November 15th, there was short interest totalling 4,900 shares, a decline of 98.9% from the October 31st total of 429,500 shares. Based on an average daily trading volume, of 40,600 shares, the days-to-cover ratio is presently 0.1 days.

CSPC Pharmaceutical Group Stock Up 3.1 %

CSPCY traded up C$0.08 during trading on Wednesday, reaching C$2.64. 5,526 shares of the stock were exchanged, compared to its average volume of 40,428. The business’s 50 day moving average price is C$2.93 and its two-hundred day moving average price is C$2.97. CSPC Pharmaceutical Group has a 1 year low of C$2.25 and a 1 year high of C$3.82.

CSPC Pharmaceutical Group Increases Dividend

The company also recently announced a dividend, which will be paid on Thursday, December 5th. Shareholders of record on Friday, November 1st will be given a dividend of $0.0575 per share. This is an increase from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date is Friday, November 1st.

About CSPC Pharmaceutical Group

(Get Free Report)

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.

Further Reading